Periodontal Therapeutics Market Developments by 2031
Periodontal therapeutics are products used in treatment of periodontal disease. Periodontitis is chronic bacterial infection caused due to microbial plaque often known as gum disease, which is colonized on tooth surface and below the gingival margin. Periodontal disease are caused due to hormonal changes, smoking, poor oral health hygiene and some hereditary factors. The periodontal disease involves progressive loss of alveolar bone and majorly observed in adults.
MARKET DYNAMICS
The global periodontal therapeutics market is expected to grow due to rise in geriatric population, increase in prevalence of periodontal disease due to changing lifestyle, increased tooth retention which leads to periodontitis, reduced side effect of drugs, low dose requirement for treatment and others. On the other hand advancement in treatment by using novel drug and increase in preference to local drug for treatment of periodontal disease are expected to offer new opportunities in market growth.
MARKET SCOPE
The "Global Periodontal Therapeutics Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of periodontal therapeutics market with detailed market segmentation by drug type, distribution channel and geography. The global periodontal therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading periodontal therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global periodontal therapeutics market is segmented on the basis of drug type and distribution channel Based on drug type, the market is segmented as arestin, atridox, doxycycline, metronidazole, minocycline, periochip and others. Based on distribution channel the market is segmented as hospital pharmacies, retail pharmacies and online channel
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global periodontal therapeutics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The periodontal therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting periodontal therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the periodontal therapeutics market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global periodontal therapeutics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The periodontal therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting periodontal therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the periodontal therapeutics market in these regions.
MARKET PLAYERSThe reports cover key developments in the periodontal therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from periodontal therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for periodontal therapeutics in the global market. Below mentioned is the list of few companies engaged in the periodontal therapeutics market.
The report also includes the profiles of key periodontal therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Tolmar Pharmaceuticals, Inc.
- Eli Lilly and Company
- Align Technology, Inc.
- 3M
- Ultradent Products Inc.
- Nobel Biocare Services AG
- Glidewell Laboratories
- Den-Mat Holdings, LLC
- Mallinckrodt.
- Teva Pharmaceutical Industries Ltd
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Periodontal Therapeutics Market - By Drug Type
1.3.2 Periodontal Therapeutics Market - By Distribution Channel
1.3.3 Periodontal Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PERIODONTAL THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PERIODONTAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PERIODONTAL THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PERIODONTAL THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. PERIODONTAL THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PERIODONTAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ARESTIN
7.3.1. Overview
7.3.2. Arestin Market Forecast and Analysis
7.4. ATRIDOX
7.4.1. Overview
7.4.2. Atridox Market Forecast and Analysis
7.5. DOXYCYCLINE
7.5.1. Overview
7.5.2. Doxycycline Market Forecast and Analysis
7.6. METRONIDAZOLE
7.6.1. Overview
7.6.2. Metronidazole Market Forecast and Analysis
7.7. MINOCYCLINE
7.7.1. Overview
7.7.2. Minocycline Market Forecast and Analysis
7.8. PERIOCHIP
7.8.1. Overview
7.8.2. Periochip Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. PERIODONTAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE CHANNEL
8.5.1. Overview
8.5.2. Online Channel Market Forecast and Analysis
9. PERIODONTAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Periodontal Therapeutics Market Overview
9.1.2 North America Periodontal Therapeutics Market Forecasts and Analysis
9.1.3 North America Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.1.4 North America Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Periodontal Therapeutics Market
9.1.5.1.1 United States Periodontal Therapeutics Market by Drug Type
9.1.5.1.2 United States Periodontal Therapeutics Market by Distribution Channel
9.1.5.2 Canada Periodontal Therapeutics Market
9.1.5.2.1 Canada Periodontal Therapeutics Market by Drug Type
9.1.5.2.2 Canada Periodontal Therapeutics Market by Distribution Channel
9.1.5.3 Mexico Periodontal Therapeutics Market
9.1.5.3.1 Mexico Periodontal Therapeutics Market by Drug Type
9.1.5.3.2 Mexico Periodontal Therapeutics Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Periodontal Therapeutics Market Overview
9.2.2 Europe Periodontal Therapeutics Market Forecasts and Analysis
9.2.3 Europe Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Periodontal Therapeutics Market
9.2.5.1.1 Germany Periodontal Therapeutics Market by Drug Type
9.2.5.1.2 Germany Periodontal Therapeutics Market by Distribution Channel
9.2.5.2 France Periodontal Therapeutics Market
9.2.5.2.1 France Periodontal Therapeutics Market by Drug Type
9.2.5.2.2 France Periodontal Therapeutics Market by Distribution Channel
9.2.5.3 Italy Periodontal Therapeutics Market
9.2.5.3.1 Italy Periodontal Therapeutics Market by Drug Type
9.2.5.3.2 Italy Periodontal Therapeutics Market by Distribution Channel
9.2.5.4 Spain Periodontal Therapeutics Market
9.2.5.4.1 Spain Periodontal Therapeutics Market by Drug Type
9.2.5.4.2 Spain Periodontal Therapeutics Market by Distribution Channel
9.2.5.5 United Kingdom Periodontal Therapeutics Market
9.2.5.5.1 United Kingdom Periodontal Therapeutics Market by Drug Type
9.2.5.5.2 United Kingdom Periodontal Therapeutics Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Periodontal Therapeutics Market Overview
9.3.2 Asia-Pacific Periodontal Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Periodontal Therapeutics Market
9.3.5.1.1 Australia Periodontal Therapeutics Market by Drug Type
9.3.5.1.2 Australia Periodontal Therapeutics Market by Distribution Channel
9.3.5.2 China Periodontal Therapeutics Market
9.3.5.2.1 China Periodontal Therapeutics Market by Drug Type
9.3.5.2.2 China Periodontal Therapeutics Market by Distribution Channel
9.3.5.3 India Periodontal Therapeutics Market
9.3.5.3.1 India Periodontal Therapeutics Market by Drug Type
9.3.5.3.2 India Periodontal Therapeutics Market by Distribution Channel
9.3.5.4 Japan Periodontal Therapeutics Market
9.3.5.4.1 Japan Periodontal Therapeutics Market by Drug Type
9.3.5.4.2 Japan Periodontal Therapeutics Market by Distribution Channel
9.3.5.5 South Korea Periodontal Therapeutics Market
9.3.5.5.1 South Korea Periodontal Therapeutics Market by Drug Type
9.3.5.5.2 South Korea Periodontal Therapeutics Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Periodontal Therapeutics Market Overview
9.4.2 Middle East and Africa Periodontal Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Periodontal Therapeutics Market
9.4.5.1.1 South Africa Periodontal Therapeutics Market by Drug Type
9.4.5.1.2 South Africa Periodontal Therapeutics Market by Distribution Channel
9.4.5.2 Saudi Arabia Periodontal Therapeutics Market
9.4.5.2.1 Saudi Arabia Periodontal Therapeutics Market by Drug Type
9.4.5.2.2 Saudi Arabia Periodontal Therapeutics Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Periodontal Therapeutics Market Overview
9.5.2 South and Central America Periodontal Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Periodontal Therapeutics Market
9.5.5.1.1 Brazil Periodontal Therapeutics Market by Drug Type
9.5.5.1.2 Brazil Periodontal Therapeutics Market by Distribution Channel
9.5.5.2 Argentina Periodontal Therapeutics Market
9.5.5.2.1 Argentina Periodontal Therapeutics Market by Drug Type
9.5.5.2.2 Argentina Periodontal Therapeutics Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PERIODONTAL THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. TOLMAR PHARMACEUTICALS, INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ELI LILLY AND COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ALIGN TECHNOLOGY, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. 3M
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ULTRADENT PRODUCTS INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOBEL BIOCARE SERVICES AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLIDEWELL LABORATORIES
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. DEN-MAT HOLDINGS, LLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MALLINCKRODT.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Tolmar Pharmaceuticals, Inc.
2. Eli Lilly and Company
3. Align Technology, Inc.
4. 3M
5. Ultradent Products Inc.
6. Nobel Biocare Services AG
7. Glidewell Laboratories
8. Den-Mat Holdings, LLC
9. Mallinckrodt.
10. Teva Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For